Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | Director | March 31, 2021 | April 02, 2021 |
| UNIVERSAL CORP /VA/UVV · Entity 4866 | Director | March 31, 2020 | May 15, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date March 31, 2021 · Filed April 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 28,816 |
Reported balance
After 2021-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-03-31 · Grant · Acquired 2 · Balance 28,816 F1: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2: Shares acquired through quarterly dividend reinvestment transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).
F2: Shares acquired through quarterly dividend reinvestment transaction.
UNIVERSAL CORP /VA/
Report date March 31, 2020 · Filed May 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - Dividend Reinvestment PlanSEC Table I · non-derivative | Direct | 5,241 |
Reported balance
Holding disclosure · report date 2020-03-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,241 F1: Includes 788 shares acquired 4/1/19 through 3/31/20 in the Dividend Reinvestment Plan. |
| Common StockSEC Table I · non-derivative | Direct | 22,945 |
Reported balance
Holding disclosure · report date 2020-03-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 22,945 F2: Includes 9,650 restricted stock shares granted for service as a director. Also includes 4,700 restricted stock units and 372 dividend equivalent units earned on the restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 788 shares acquired 4/1/19 through 3/31/20 in the Dividend Reinvestment Plan.
F2: Includes 9,650 restricted stock shares granted for service as a director. Also includes 4,700 restricted stock units and 372 dividend equivalent units earned on the restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2021 Filed Apr 2, 2021 12:28 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 2 | $37.59 | $75.18 |
DisclosureSEC source: 0000075252-21-000063 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,816 Underlying: Common Stock · 2 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 13:26 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 3 | $27.05 | $81.15 |
DisclosureSEC source: 0000075252-21-000004 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,814 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:41 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 3 | $25.11 | $75.33 |
DisclosureSEC source: 0000075252-20-000126 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,811 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 15:57 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 9 | $7.62 | $68.58 |
DisclosureSEC source: 0000075252-20-000093 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,808 Underlying: Common Stock · 9 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 17,242 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000059 · edgar.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,893 F1 · security: Restricted stock with a one year vesting date. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 22:50 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 8 | $9.15 | $73.20 |
DisclosureSEC source: 0000075252-20-000039 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,799 Underlying: Common Stock · 8 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:12 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 14 | $5.17 | $72.38 |
DisclosureSEC source: 0000075252-20-000002 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,791 Underlying: Common Stock · 14 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 00:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 12 | $5.81 | $69.72 |
DisclosureSEC source: 0000075252-19-000117 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,777 Underlying: Common Stock · 12 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 20:59 UTC | UNIVERSAL CORP /VA/ UVV · Entity 4866 | GrantCommon Stock | 1,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001225385-19-000165 · edgar.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,643 F1 · kind: Award of 1,650 restricted stock units for service as a director. The restricted stock units vest on the first anniversary of the award date. F2 · balance_after: Includes 9,650 shares of restricted stock, 4,700 restricted stock units and 233 dividend equivalent units earned on the restricted stock units. F3 · balance_after: Includes shares not previously reported that were acquired through the Dividend Reinvestment Plan. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:12 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 22 | $3.20 | $70.40 |
DisclosureSEC source: 0000075252-19-000098 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,765 Underlying: Common Stock · 22 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:50 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 32,637 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-19-000083 · edgar.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,651 F1 · security: Restricted stock with a one year vesting date. F2 · balance_after: Total reflects shares acquired through dividend reinvestment transactions not previously included in beneficial ownership. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 21:01 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 18 | $4.10 | $73.80 |
DisclosureSEC source: 0000075252-19-000059 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,743 Underlying: Common Stock · 18 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 19:37 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 327 | $6.51 | $2,128.77 |
DisclosureSEC source: 0000075252-19-000002 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,725 Underlying: Common Stock · 327 shares Expires not disclosed F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · shares: Shares acquired through quarterly dividend reinvestment transaction. F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 21:27 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 447 | $16.26 | $7,268.22 |
DisclosureSEC source: 0000075252-18-000129 · edgar.xml · derivative · entry 2 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,398 Underlying: Common Stock · 447 shares Expires not disclosed F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · shares: Shares acquired through quarterly dividend reinvestment transaction. F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 21:27 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 14.018 | $16.68 | $233.88 |
DisclosureSEC source: 0000075252-18-000129 · edgar.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,030.518 F1 · shares: Shares acquired through quarterly dividend reinvestment transaction. Read SEC document |
| August 02, 2018 Filed Aug 2, 2018 20:32 UTC | UNIVERSAL CORP /VA/ UVV · Entity 4866 | GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-035155 · doc1.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,840 F1 · kind: Award of 1,500 restricted stock units for service as a director. The restricted stock units vest on the third anniversary of the award date; payment, however, will be delayed until certain restrictions are met. F2 · price: The value of each restricted stock unit ($66.2631) was based upon Bloomberg LLP daily volume weighted average between June 1, 2018 and July 31, 2018. F3 · balance_after: Includes 9,650 shares of restricted stock, 5,550 restricted stock units and 273 dividend equivalent units earned on the restricted stock units. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 18:22 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 430 | $16.63 | $7,150.90 |
DisclosureSEC source: 0000075252-18-000104 · edgar.xml · derivative · entry 2 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,951 Underlying: Common Stock · 430 shares Expires not disclosed F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · shares: Shares acquired through quarterly dividend reinvestment transaction. F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| June 28, 2018 Filed Jul 3, 2018 18:22 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 13.5 | $17.06 | $230.26 |
DisclosureSEC source: 0000075252-18-000104 · edgar.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,016.5 F1 · shares: Shares acquired through quarterly dividend reinvestment transaction. Read SEC document |
| June 06, 2018 Filed Jun 6, 2018 21:05 UTC | UNIVERSAL CORP /VA/ UVV · Entity 4866 | SaleCommon Stock | 2,000 | $65.57 | $131,144.00 |
DisclosureSEC source: 0001140361-18-027570 · doc1.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,340 F1 · balance_after: 9,650 Restricted stock shares were granted for service as a director. Transfer of shares is prohibited and the shares may be forfeited to the Company unless certain specified conditions are met. Also includes 4,050 restricted stock units and 273 dividend equivalent units earned on the restricted stock units. The restricted stock units vest on the third anniversary of the award date, however, payment will be delayed until certain restrictions are met. Read SEC document |
| May 17, 2018 Filed May 18, 2018 16:37 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 10,355 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-18-000081 · edgar.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,003 F1 · security: Restricted stock with a one year vesting date. F2 · balance_after: Total reflects shares acquired through dividend reinvestment transactions not previously included in beneficial ownership. Read SEC document |
| March 31, 2018 Filed May 14, 2018 20:15 UTC | UNIVERSAL CORP /VA/ UVV · Entity 4866 | OtherCommon Stock-Dividend Reinvestment Plan | 493 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-023332 · doc1.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,813 F1 · price: Shares acquired 4/1/17 through 3/31/18 in the Dividend Reinvestment Plan. F1 · balance_after: Shares acquired 4/1/17 through 3/31/18 in the Dividend Reinvestment Plan. Read SEC document |
| March 30, 2018 Filed Apr 2, 2018 22:23 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 466 | $15.09 | $7,031.94 |
DisclosureSEC source: 0000075252-18-000060 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,521 Underlying: Common Stock · 466 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 15:52 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 364 | $18.88 | $6,872.32 |
DisclosureSEC source: 0000075252-18-000004 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,055 Underlying: Common Stock · 364 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 18:41 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 233 | $29.20 | $6,803.60 |
DisclosureSEC source: 0000075252-17-000117 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,691 Underlying: Common Stock · 233 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 21:20 UTC | UNIVERSAL CORP /VA/ UVV · Entity 4866 | GrantCommon Stock | 1,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-030378 · doc1.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,615 F1 · kind: Award of 1,550 restricted stock units for service as a director. The restricted stock units vest on the third anniversary of the award date; payment, however, will be delayed until certain restrictions are met. F2 · price: The value of each restricted stock unit ($65.0199) was based upon Bloomberg LLP daily volume weighted average between June 1, 2017 and July 31, 2017. F3 · balance_after: Includes 9,650 shares of restricted stock, 5,350 restricted stock units and 257 dividend equivalent units earned on the restricted stock units. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:33 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 210 | $32.19 | $6,759.90 |
DisclosureSEC source: 0000075252-17-000096 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,458 Underlying: Common Stock · 210 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 05, 2017 Filed May 8, 2017 20:45 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-17-000079 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,248 Underlying: Common Stock · 3,050 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:39 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 171 | $34.60 | $5,916.60 |
DisclosureSEC source: 0000075252-17-000058 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,198 Underlying: Common Stock · 171 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| March 31, 2017 Filed May 11, 2017 19:19 UTC | UNIVERSAL CORP /VA/ UVV · Entity 4866 | OtherCommon Stock-Dividend Reinvestment Plan | 452 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-019697 · doc1.xml · nonDerivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,320 F1 · price: Shares acquired 4/1/16 through 3/31/17 in the Dividend Reinvestment Plan. F1 · balance_after: Shares acquired 4/1/16 through 3/31/17 in the Dividend Reinvestment Plan. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 14:13 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 165 | $35.29 | $5,822.85 |
DisclosureSEC source: 0000075252-17-000002 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,027 Underlying: Common Stock · 165 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 20:36 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 167 | $34.73 | $5,799.91 |
DisclosureSEC source: 0000075252-16-000213 · edgar.xml · derivative · entry 1 MOORE EDDIE N JR · CIK 0001114771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,862 Underlying: Common Stock · 167 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.